The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Reduction of Cancer Related Fatigue in Patients During TKI Therapy
Official Title: Pilot Study on the Effects of Strength Training on Cancer Related Fatigue in Cancer Patients During Tyrosine Kinase Inhibitor Therapy
Study ID: NCT01645150
Brief Summary: The purpose of this pilot study is to determine the effects of a 12-week resistance training program on cancer related fatigue in cancer patients receiving tyrosine kinase inhibitor (TKI) therapy. It is hypothesized that incidence and severity of cancer related fatigue can be reduced by exercise training in this population which leads to an improved treatment completion rate.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
National Center for Tumor Diseases Heidelberg (German Cancer Research Center/University Hospital Heidelberg), Heidelberg, , Germany
Name: Carsten Grüllich, MD
Affiliation: National Center for Tumor Diseases Heidelberg (GermanCRC/University Hospital Heidelberg) Germany
Role: PRINCIPAL_INVESTIGATOR
Name: Friederike Scharhag-Rosenberger, PhD
Affiliation: National Center for Tumor Diseases Heidelberg (GermanCRC/University Hospital Heidelberg) Germany
Role: PRINCIPAL_INVESTIGATOR
Name: Joachim Wiskamann, PhD
Affiliation: National Center for Tumor Diseases Heidelberg (GermanCRC/University Hospital Heidelberg) Germany
Role: PRINCIPAL_INVESTIGATOR
Name: Dirk Jäger, Professor
Affiliation: National Center for Tumor Diseases Heidelberg (GermanCRC/University Hospital Heidelberg) Germany
Role: STUDY_CHAIR
Name: Karen Steindorf, Professor
Affiliation: National Center for Tumor Diseases Heidelberg (GermanCRC/University Hospital Heidelberg) Germany
Role: STUDY_CHAIR